The North Carolina Department of Health and Human Services announced four new locations offering monoclonal antibodies (mAbs) for treatment of COVID-19 managed by local organizations in partnership with the Federal Emergency Management Agency, bringing the number of sites in the state offering this therapy to more than 200. FEMA will also help staff one existing site. This partnership will give more North Carolinians access to monoclonal antibody treatment, which can decrease the likelihood of hospitalization related to COVID-19 if taken early.